Tess Holliday reflects on a pivotal 2019 when plus-size fashion flourished, marked by diversity in runway shows and media representation. However, the onset of the pandemic shifted perceptions, leading to increased scrutiny of appearances and a retreat from plus-size offerings by major brands. With the advent of weight-loss medications like Ozempic, a renewed focus on thinness prevails in fashion. Many in the industry are reluctant to support plus-size lines despite the vast demographic of plus-size women. Holliday expresses concern that the landscape for body positivity may not recover as the industry leans towards conventional ideals.
It's difficult to envision a return to pre-pandemic levels of body positivity as brands continue to focus more on conventional beauty standards and thinness.
The fashion industry faces operational challenges with manufacturing plus-size clothing, leading brands to actively avoid serving that market even if demand exists.
Collection
[
|
...
]